Kiplinger

Marijuana Stocks: Headed Higher?

The Green Rush may be upon us. Cannabis investment research firm ArcView estimates that legal North American marijuana sales hit more than $8 billion in 2017, up 22% from the year before. What's more, the firm expects annual sales to grow by 27% per year through the end of 2021, reaching $22.6 billion at that point. Investors have begun speculating accordingly - the ETFMG Alternative Harvest ETF (MJX), an exchange-traded fund that invests in marijuana stocks, has returned 14% since mid-December.

Driving much of the speculation: our neighbors to the north. Canada, where medical marijuana is already legal, is expected to legalize and regulate pot for recreational use by July. The market for legal pot is growing stateside as well. Twenty-nine states and the District of Columbia have legalized marijuana for medical purposes, and nine states and D.C. allow recreational marijuana use.

However, pot

You’re reading a preview, subscribe to read more.

More from Kiplinger

Kiplinger5 min read
4 Steps for Managing Income Withdrawals in Retirement
If you’re like most Americans nearing retirement, you’re worried about whether you have enough savings. In fact, only 22% of those approaching retirement believe they’ve saved enough to retire comfortably. At a time when the stock market is down, inf
Kiplinger3 min read
Calling All Teachers: You Can Deduct More for School Supplies for 2022
The school year has begun, and teachers are dealing with the normal pressures of managing students and classrooms. But lately, there is additional stress for educators, ranging from teacher shortages to possible teacher strikes. And to top it off, in
Kiplinger5 min read
As the Market Falls, New Retirees Need a Plan
Anyone newly retired or nearly so must feel like they have the worst timing in the world. A portfolio tends to be largest near retirement, just before those savings are about to be drawn down. These days, however, most portfolios have lost value; the

Related Books & Audiobooks